Patent ID: 11903956
Assignee: B & H BIOTECHNOLOGIES, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A method for treating an infectious disease, inflammatory disease or infection-relating disease or condition, the method comprising administering an effective amount of a composition to a patient diagnosed with an infectious disease, inflammatory disease or an infection-relating disease or condition, wherein the composition comprises:
(a) about 0.01 mg/mL to about 20 mg/mL of N-acetylneuraminic acid;
(b) about 0.01 mg/mL to about 20 mg/mL of N-acetylneuraminic acid methyl ester; and
(c) about ¼ to about ¾ of the manufacturer's recommended dose of Tamiflu for the treatment of influenza; or
(d) about ¼ to about ¾ of the manufacturer's recommended dose of Enrofloxacin for the treatment of rotavirus infection or diarrhea; or
(e) about ¼ to about ¾ of the manufacturer's recommended dose of Cephradine for the treatment of diarrhea gastroenteritis; and, wherein the infectious disease, inflammatory disease or an infection-relating disease or condition is gastroenteritis, diarrhea, or viral infection caused by influenza or rotavirus.